Non-Small Cell Lung Cancer New Indication: Osimertinib in First-Line NSCLC Ulas D. Bayraktar, MD 2023-11-20
Non-Small Cell Lung Cancer New Indication: Trastuzumab Deruxtecan for her2 Mutant NSCLC Ulas D. Bayraktar, MD 2023-09-23
Non-Small Cell Lung Cancer New Indication: Pembrolizumab for Early-Stage NSCLC Ulas D. Bayraktar, MD 2023-08-20
Non-Small Cell Lung Cancer New Indication: Perioperative Nivolumab and Chemotherapy for Stage III NSCLC Ulas D. Bayraktar, MD 2023-08-20
Non-Small Cell Lung Cancer New Reference: Encorafenib and Binimetinib in bRAF V600E Mutated NSCLC Ulas D. Bayraktar, MD 2023-06-24
Non-Small Cell Lung Cancer New Drug: Pralsetinib for non-small cell lung cancer with RET gene fusions Ulas D. Bayraktar, MD 2023-06-07
Non-Small Cell Lung Cancer New Indication: Adjuvant Pembrolizumab for NSCLC Ulas D. Bayraktar, MD 2023-03-15
Non-Small Cell Lung Cancer New Protocol: Cemiplimab with Chemotherapy in NSCLC Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Indication: Durvalumab with Tremelimumab in Metastatic NSCLC Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Indication: Adjuvant Pembrolizumab in NSCLC Ulas D. Bayraktar, MD 2022-11-26
